Know someone who should be publicly acknowledged for his/her contributions to histocompatibility and immunogenetics? ASHI has opened nominations to the membership for the following awards! Click here to view awards and requirements. Click here to view previous winners.

ASHI submitted a letter to the FDA regarding draft guidance for (510(k)) submissions for nucleic acid-based HLA test kits. Because a section of this draft guidance will have such a negative impact on both manufacturers and laboratories, we asked other organizations and our valued vendors to support ASHI's comments by forwarding this letter to the FDA along with their own letters. Click here to view ASHI's letter.

The ASHI Nominations Committee encourages ASHI members to nominate candidates for all available board positions.  If there are candidates you feel would be an asset to the ASHI Board of Directors, please complete and submit a nomination form to ASHI. All nominations must be accompanied by the signatures of at least 10 full or honorary members in good standing. Email endorsements are acceptable.

By April 5th, the Nominations Committee will forward its preliminary slate of candidates to the ASHI membership. This will allow members 30 days to submit their own nominations by the May 5th deadline. Click here for the nominations form.